Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Cullen
FOU | Founder | 78 | 21-09-11 |
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16-07-20 |
Susan Horvath
DFI | Director of Finance/CFO | 65 | 17-04-18 |
Tammy Groene
COO | Chief Operating Officer | - | 01-04-12 |
Chief Tech/Sci/R&D Officer | - | 01-06-22 | |
Rachel Bragg
PRN | Corporate Officer/Principal | - | 01-06-21 |
- | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer Simpson
CEO | Chief Executive Officer | 55 | 16-07-20 |
Director/Board Member | 63 | 30-09-15 | |
Michael Cullen
FOU | Founder | 78 | 21-09-11 |
Jeffrey Jacob
BRD | Director/Board Member | 62 | 15-06-22 |
Arthur Fratamico
BRD | Director/Board Member | 58 | 16-12-19 |
Dan Donovan
BRD | Director/Board Member | 59 | 15-06-22 |
Donald Schemel
BRD | Director/Board Member | 68 | 04-09-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 4 854 931 | 4 854 791 ( 100,00 %) | 70 ( 0,001442 %) | 100,00 % |
Bedrijfsgegevens
Panbela Therapeutics, Inc.
712 Vista Boulevard Suite 305
55387, Waconia
+952 479 1196
http://www.panbela.comVaira. 1 jan. | Kapi. | |
---|---|---|
+14,09% | 3.161 mld. | |
+11,00% | 87,62 mld. | |
+6,51% | 79,59 mld. | |
-12,92% | 54,14 mld. | |
+23,70% | 48,15 mld. | |
+32,92% | 47,69 mld. | |
-25,15% | 46,81 mld. | |
+80,89% | 42 mld. | |
-5,92% | 25,77 mld. |